CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The goal of this clinical research study is to learn if Niraparib can help to control metastatic pancreatic cancer. The safety of t...
Phase 2
Kansas City, Kansas, United States and 5 other locations
with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...
Phase 3
Kansas City, Missouri, United States and 89 other locations
ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...
Phase 1, Phase 2
Merriam, Kansas, United States and 27 other locations
open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...
Phase 1, Phase 2
Kansas City, Kansas, United States and 15 other locations
Researchers want to discover if the new drug "TG01" will work with participants' bodies to help their immune system attack any cancer cells ...
Phase 2
Kansas City, Missouri, United States and 4 other locations
This trial will study tisotumab vedotin to find out whether it is an effective treatment for certain solid tumors and what side effects (unwanted eff...
Phase 2
Fairway, Kansas, United States and 60 other locations
This is a phase 1 first in human, dose escalation trial of GP-2250 administered in combination with gemcitabine in subjects with advanced pancreatic...
Phase 1
Fairway, Kansas, United States and 3 other locations
and efficacy of 9-ING-41, a potent GSK-3β inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers...
Phase 2
Kansas City, Kansas, United States and 65 other locations
The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...
Phase 2
Saint Joseph, Missouri, United States and 79 other locations
nivolumab or standard of care. It is being tested against advanced and/or metastatic solid tumors including gastric, gastroesophageal junction, pancreatic...
Phase 1, Phase 2
Kansas City, Kansas, United States and 18 other locations
Clinical trials
Research sites
Resources
Legal